Article Details
Retrieved on: 2018-07-05 10:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Hangzhou-based biopharmaceutical company Adlai Nortye Biopharma announced that it has raised a US$53 million series B round from <b>Matrix</b> ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here